BeOne Medicines Ltd
81 hedge funds and large institutions have $2.61B invested in BeOne Medicines Ltd in 2017 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 32 increasing their positions, 13 reducing their positions, and 4 closing their positions.
625% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 4
197% more call options, than puts
Call options by funds: $7.15M | Put options by funds: $2.41M
184% more capital invested
Capital invested by funds: $918M → $2.61B (+$1.69B)
146% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 13
50% more funds holding in top 10
Funds holding in top 10: 6 → 9 (+3)
42% more funds holding
Funds holding: 57 → 81 (+24)
0.91% more ownership
Funds ownership: 3.93% → 4.84% (+0.91%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$96.6M |
| 2 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
+$44.7M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$37.3M |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$25M |
| 5 |
Janus Henderson Group
London,
|
+$24.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AG
Artal Group
Luxembourg
|
-$13M |
| 2 |
Brown Advisory
Baltimore,
Maryland
|
-$11M |
| 3 |
MAM
Myriad Asset Management
North Point,
Hong Kong
|
-$11M |
| 4 |
ACM
Ariose Capital Management
Central, Hong Kong,
Hong Kong
|
-$10.5M |
| 5 |
ERSOT
Employees Retirement System of Texas
Austin,
Texas
|
-$2.85M |
ONC Hedge Fund Activity: Q3 2017 in Review
81 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in BeOne Medicines Ltd (ONC) for Q3 2017, worth a combined $2.61B — up 184% from $918M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new ONC positions and 4 closed out — a net gain of 25 holders — while 32 added to existing stakes and 13 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $96.6M. The largest seller was Artal Group, cutting an estimated $13M.
- 81 institutional investors held BeOne Medicines Ltd (ONC) as of Q3 2017, up from 57 in Q2 2017.
- Funds reported $2.61B of BeOne Medicines Ltd stock for Q3 2017, up 184% quarter-over-quarter.
- 29 funds opened new BeOne Medicines Ltd positions in Q3 2017 and 4 closed out, a net change of +25 holders.
- The largest BeOne Medicines Ltd buyer in Q3 2017 was Wellington Management Group, an estimated $96.6M added.
- The largest BeOne Medicines Ltd seller in Q3 2017 was Artal Group, an estimated $13M sold.
Based on aggregated 13F filings for Q3 2017.